The research firm initiated coverage of the med-tech stock with a buy rating.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Buy the dip on GE Healthcare, says Needham
